AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Return on equity (%)

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥84.2B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on equity (%) (Million JPY)YoY (%)
Dec 31, 2025-41.8+484.06%
Dec 31, 2024-7.1-37.99%
Dec 31, 2023-11.5-1846.97%
Dec 31, 20220.7-64.32%
Dec 31, 20211.9-39.14%
Dec 31, 20203+11.36%
Dec 31, 20192.7-122.51%
Dec 31, 2018-12.1+129.73%
Mar 31, 2018-5.3-121.59%
Mar 31, 201724.5-670.16%
Mar 31, 2016-4.3-326.98%
Mar 31, 20151.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)